Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2002 3
2003 2
2007 1
2008 1
2009 1
2010 3
2011 2
2012 2
2013 4
2014 1
2015 3
2016 3
2017 1
2018 1
2019 2
2020 9
2021 10
2022 6
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gilbert L, Oaknin A, Matulonis UA, Mantia-Smaldone GM, Lim PC, Castro CM, Provencher D, Memarzadeh S, Method M, Wang J, Moore KN, O'Malley DM. Gilbert L, et al. Among authors: memarzadeh s. Gynecol Oncol. 2023 Mar;170:241-247. doi: 10.1016/j.ygyno.2023.01.020. Epub 2023 Feb 1. Gynecol Oncol. 2023. PMID: 36736157 Free article.
Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation.
Bai M, Gallen E, Memarzadeh S, Howie J, Gao X, Kuo CS, Brown E, Swingler S, Wilson SJ, Shattock MJ, France DJ, Fuller W. Bai M, et al. Among authors: memarzadeh s. PLoS One. 2024 Mar 21;19(3):e0299665. doi: 10.1371/journal.pone.0299665. eCollection 2024. PLoS One. 2024. PMID: 38512906 Free PMC article.
[68Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor.
Unterrainer LM, Memarzadeh S, Moatamed NA, Benz MR, Czernin J, Calais J. Unterrainer LM, et al. Among authors: memarzadeh s. J Nucl Med. 2024 Jan 11:jnumed.123.266732. doi: 10.2967/jnumed.123.266732. Online ahead of print. J Nucl Med. 2024. PMID: 38212069 No abstract available.
61 results